Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients

Clinical trial NCT01055821 · COMPLETED

Trial details

NCT number: NCT01055821
Sponsor: Transgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C Infection

Start date: 2010-05-01
Primary completion: 2012-10-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.